标普和纳斯达克内在价值 联系我们

MedTech Acquisition Corporation MTAC NASDAQ

NASDAQ Capital Marke • Financial Services • Shell Companies • US • USD

SharesGrow Score
34/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

共有 33 笔近期内部人交易记录记录,涉及 MedTech Acquisition Corporation (MTAC), 包括 14 笔买入14 笔卖出. 内部人买入总额为 $9.01M 内部人卖出总额为 $5.27M.

近期活跃的重要内部人包括 Devlin Jodi, Szela Mary T, Murphy Sean. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.

内部人交易记录 — MTAC

日期 姓名 职位 交易类型 股数 平均价格 总价值 持股数量
2023-08-30 Devlin Jodi President, Therapeutics 限制性股票授予 (RSU) 195,000 $6.70 $1.31M 195,000
2023-08-28 Devlin Jodi Officer 未知 - - - -
2023-08-14 Szela Mary T CEO and President 限制性股票授予 (RSU) 172,500 $11.51 $1.99M 172,500
2023-08-11 Murphy Sean Chief Financial Officer 限制性股票授予 (RSU) 62,500 $12.00 $750K 62,500
2023-08-11 Cox Bryan F. Chief Scientific & Manufact. 限制性股票授予 (RSU) 40,000 $12.00 $480K 40,000
2023-08-11 Stevens Jennifer Chief Regulatory Officer 限制性股票授予 (RSU) 40,000 $12.00 $480K 40,000
2023-08-11 Marshak Richard Sr.vp, Corp. Dev. & Strategy 限制性股票授予 (RSU) 40,000 $12.00 $480K 40,000
2023-08-11 Katz Steven C Chief Medical Officer 限制性股票授予 (RSU) 62,500 $12.00 $750K 62,500
2023-08-10 Hicks Kerry R Director 处置 4,943 $2.43 $12.01K -
2023-08-10 Hicks Kerry R Director 限制性股票授予 (RSU) 35,000 $11.34 $396.9K 35,000
2023-08-10 Matlin David J Director 限制性股票授予 (RSU) 35,000 $11.34 $396.9K 35,000
2023-08-10 Wahlstrom Mats 10 Percent Owner 未知 50,000 $10.00 $500K -
2023-08-10 Wahlstrom Mats 10 Percent Owner 限制性股票授予 (RSU) 35,000 $11.34 $396.9K 35,000
2023-08-10 Von Eschenbach Andrew C. Director 未知 - - - -
2023-08-10 Von Eschenbach Andrew C. Director 限制性股票授予 (RSU) 35,000 $11.34 $396.9K 35,000
2023-08-10 Murphy Sean Chief Financial Officer 处置 31,287 $10.30 $322.26K -
2023-08-10 Alecxih James President, Device Technology 处置 94,754 $10.30 $975.97K -
2023-08-10 Cox Bryan F. Chief Scientific & Manufact. 处置 8,391 $10.30 $86.43K -
2023-08-10 Martin George Kelly Director 未知 - - - -
2023-08-10 Martin George Kelly Director 限制性股票授予 (RSU) 35,000 $11.34 $396.9K 35,000
2023-08-10 Stevens Jennifer Chief Regulatory Officer 处置 8,391 $10.30 $86.43K -
2023-08-10 Marshak Richard Sr.vp, Corp. Dev. & Strategy 处置 8,391 $10.30 $86.43K -
2023-08-10 Singhal Anil K. Director 处置 12,359 $2.43 $30.03K -
2023-08-10 Singhal Anil K. Director 限制性股票授予 (RSU) 35,000 $11.34 $396.9K 35,000
2023-08-10 Desai Arjun Jj Director 处置 - - - 203,127
2023-08-10 Desai Arjun Jj Director 限制性股票授予 (RSU) 35,000 $11.34 $396.9K 35,000
2023-08-10 Katz Steven C Chief Medical Officer 处置 31,040 $10.30 $319.71K -
2023-08-10 Frankenius Equity Ab 10 Percent Owner 处置 230,000 $10.00 $2.3M -
2023-08-10 Szela Mary T CEO and President 处置 58,409 $10.30 $601.61K -
2023-06-26 Medtech Acquisition Sponsor Llc 10 Percent Owner 转换(卖出) 6,249,999 - - 1
2023-06-12 Magnetar Financial Llc 10 Percent Owner 其他(卖出) 42,567 $10.49 $446.36K -
2022-12-12 Magnetar Financial Llc Director 未知 - - - 21,780
2020-12-17 Desai Arjun Jj Director 处置 246,667 - - -
知情交易 — 公开市场买卖(最具参考价值) 非知情买入 — 奖励、期权行权、转换 非知情卖出 — 税务代扣、归属出售 中性 — 礼赠、信托、到期
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言